Search research articles
Contact Us
Filters
Showing results (31-40 of 103) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas
Maryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu, et al.
Human Gene Therapy
|
October 24, 2009
Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells
Marc R Theoret, Cyrille J Cohen, Azam V Nahvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2024
FDA Approval Summary: Teclistamab-A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple Myeloma
Andrea C Baines, Bindu Kanapuru, Jay Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2025
FDA approval summary: Lifileucel for unresectable or metastatic melanoma previously treated with an anti-PD-1 based immunotherapy
Lianne Hu, Chaohong Fan, Peter Bross, et al.
The Oncologist
|
April 1, 2022
FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy
Robert Q Le, Xin Wang, Hongfei Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2018
FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
Maura C O'Leary, Xiaobin Lu, Ying Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia
Daniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2017
FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen
Amy Barone, Dow-Chung Chi, Marc R Theoret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors
Leigh Marcus, Lola A Fashoyin-Aje, Martha Donoghue, et al.
Current Oncology Reports
|
August 28, 2020
Immune Response Evaluation and Treatment with Immune Checkpoint Inhibitors Beyond Clinical Progression: Response Assessments for Cancer Immunotherapy
Sirisha L Mushti, Flora Mulkey, Shenghui Tang, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 103) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-Cell Lymphomas
Maryam Sarraf Yazdy, Yvette L Kasamon, Wenjuan Gu, et al.
Human Gene Therapy
|
October 24, 2009
Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells
Marc R Theoret, Cyrille J Cohen, Azam V Nahvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2024
FDA Approval Summary: Teclistamab-A Bispecific CD3 T-Cell Engager for Patients with Relapsed or Refractory Multiple Myeloma
Andrea C Baines, Bindu Kanapuru, Jay Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2025
FDA approval summary: Lifileucel for unresectable or metastatic melanoma previously treated with an anti-PD-1 based immunotherapy
Lianne Hu, Chaohong Fan, Peter Bross, et al.
The Oncologist
|
April 1, 2022
FDA Approval Summary: Ruxolitinib for Treatment of Chronic Graft-Versus-Host Disease after Failure of One or Two Lines of Systemic Therapy
Robert Q Le, Xin Wang, Hongfei Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 13, 2018
FDA Approval Summary: Tisagenlecleucel for Treatment of Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
Maura C O'Leary, Xiaobin Lu, Ying Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 10, 2021
Project 2025: Proposals for the Continued Success of Drug Development in Acute Myeloid Leukemia
Daniel A Pollyea, John Barrett, Courtney D DiNardo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2017
FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen
Amy Barone, Dow-Chung Chi, Marc R Theoret, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 4, 2021
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors
Leigh Marcus, Lola A Fashoyin-Aje, Martha Donoghue, et al.
Current Oncology Reports
|
August 28, 2020
Immune Response Evaluation and Treatment with Immune Checkpoint Inhibitors Beyond Clinical Progression: Response Assessments for Cancer Immunotherapy
Sirisha L Mushti, Flora Mulkey, Shenghui Tang, et al.
Page
of 11